Akums Drugs Correlations

AKUMS Stock

500.45 5.25 1.04%

The current 90-days correlation between Akums Drugs and Alivus Life Sciences is 0.22 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akums Drugs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akums Drugs and moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Akums Drugs Correlation With Market

Significant diversification

The correlation between Akums Drugs and and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Akums Drugs and and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Akums Drugs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akums Drugs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akums Drugs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akums Drugs and to buy it.

Moving together with Akums Stock

0.92	EMCURE	Emcure Pharmaceuticals	Pair Corr
0.9	INNOVACAP	Innova Captab Limited	Pair Corr
0.64	KAUSHALYA	Kaushalya Infrastructure	Pair Corr

Moving against Akums Stock

0.84	BLUECOAST	Blue Coast Hotels	Pair Corr
0.31	ITDCEM	ITD Cementation India	Pair Corr

Related Correlations Analysis

	AKUMS	ALIVUS	INNOVACAP	KINGFA	RICOAUTO	GATECHDVR	COSMOFIRST	JNKINDIA	DELTAMAGNT	TBZ
AKUMS		0.5	0.9	0.81	0.87	0.74	0.85	0.9	0.89	0.7	AKUMS
ALIVUS	0.5		0.54	0.31	0.61	0.52	0.34	0.56	0.57	0.24	ALIVUS
INNOVACAP	0.9	0.54		0.86	0.9	0.67	0.89	0.85	0.89	0.76	INNOVACAP
KINGFA	0.81	0.31	0.86		0.77	0.52	0.89	0.76	0.8	0.8	KINGFA
RICOAUTO	0.87	0.61	0.9	0.77		0.86	0.86	0.83	0.96	0.72	RICOAUTO
GATECHDVR	0.74	0.52	0.67	0.52	0.86		0.72	0.65	0.86	0.61	GATECHDVR
COSMOFIRST	0.85	0.34	0.89	0.89	0.86	0.72		0.71	0.92	0.93	COSMOFIRST
JNKINDIA	0.9	0.56	0.85	0.76	0.83	0.65	0.71		0.81	0.51	JNKINDIA
DELTAMAGNT	0.89	0.57	0.89	0.8	0.96	0.86	0.92	0.81		0.81	DELTAMAGNT
TBZ	0.7	0.24	0.76	0.8	0.72	0.61	0.93	0.51	0.81		TBZ
	AKUMS	ALIVUS	INNOVACAP	KINGFA	RICOAUTO	GATECHDVR	COSMOFIRST	JNKINDIA	DELTAMAGNT	TBZ

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Risk-Adjusted Indicators

There is a big difference between Akums Stock performing well and Akums Drugs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Akums Drugs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AKUMS	2.07	(0.20)	0.00	(1.51)	0.00	0.00	4.38	(4.14)	16.95
ALIVUS	2.87	0.31	0.09	0.51	3.36	(2.93)	4.89	(5.03)	13.99
INNOVACAP	2.88	(0.11)	0.00	0.74	0.00	0.00	6.35	(5.67)	14.81
KINGFA	2.42	(0.21)	0.00	0.30	0.00	0.00	6.03	(4.35)	15.46
RICOAUTO	2.71	(0.41)	0.00	(4.80)	0.00	0.00	5.85	(5.60)	27.84
GATECHDVR	1.44	(0.18)	0.00	(1.12)	0.00	0.00	3.26	(3.30)	10.45
COSMOFIRST	2.77	(0.54)	0.00	2.28	0.00	0.00	5.16	(6.32)	16.26
JNKINDIA	2.93	(0.81)	0.00	(3.79)	0.00	0.00	7.37	(6.97)	15.62
DELTAMAGNT	2.92	(0.83)	0.00	13.67	0.00	0.00	6.16	(6.20)	19.95
TBZ	2.99	(0.52)	0.00	(3.86)	0.00	0.00	5.00	(5.63)	15.06

Be your own money manager

Our tools can tell you how much better you can do entering a position in Akums Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Valuation Now

Equity Valuation

Check real value of public entities based on technical and fundamental data

All Next

Launch Module

Akums Drugs Corporate Management

Elected by the shareholders, the Akums Drugs' board of directors comprises two types of representatives: Akums Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Akums. The board's role is to monitor Akums Drugs' management team and ensure that shareholders' interests are well served. Akums Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Akums Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.

Sunil Jaiswal	VP RD	Profile
Amrut Medhekar	Chief Business	Profile
Shantanu Chobhe	Corporate Head	Profile
Sumeet Sood	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC